title: Immunomodulators: Cell savers.
authors.forename: Sarah
authors.initials: S
authors.lastname: DeWeerdt
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000009:adverse effects; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000009:adverse effects; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D005968:Glutamate Decarboxylase / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects / Q000276:immunology; D007167:Immunotherapy; D050417:Insulin-Secreting Cells / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014807:Vitamin D / Q000494:pharmacology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000961:Antilymphocyte Serum; D014807:Vitamin D; C541220:canakinumab; D016572:Cyclosporine; D005968:Glutamate Decarboxylase; C550701:otelixizumab; C502540:teplizumab